TRPV4 and nasopharyngeal carcinoma: Furthermore, immunostaining of NPC (n = 107) and normal nasopharynx tissues (n = 63) showed that the in situ expression of TRPV4 protein was markedly higher in the tumors versus the normal tissues (Figures 1B, C).